Skip to main content
Main navigation
People
Services
Insights
Resources
Antitrust Merger StatPak (WAMS)
CFIUS FIRRMA Tool 2.0
Crisis Management
Dawn Raid Analysis Quarterly
Debt Explorer
M&A Explorer
Non-Compete Resource Center (NCRC)
US SPACs Data Hub
About Us
Our Firm
Locations
Diversity
Global Citizenship
Newsroom
2023 Annual Review
2023 Global Citizenship Review
Careers
Careers
Apply
Inside White & Case
Alumni
Breadcrumb
Home
Public Company Advisory
Public Company Advisory
Learn about our US Public Company Advisory work
Theme
Corporate Governance
Securities Regulation
Annual Memos
FPI-Specific Memos
ESG-Focused
Service
Africa
Antitrust litigation & class actions
Antitrust/Competition
Artificial Intelligence (AI)
Asia-Pacific
Asset Finance
Australia
Aviation
Bank Lending
Battery Storage
Belgium
Belt and Road Initiative (BRI)
Borrower Finance
Brazil
Business & Human Rights
Canada
Capital Markets
Carbon capture, utilization and storage (CCUS)
Cartel investigations
Central & Eastern Europe
Chemicals
Commercial Litigation
Competition compliance
Construction
Consumer & Retail
Czech Republic
Data, Privacy & Cybersecurity
Debt Finance
Derivatives
Drug Pricing
Due process
ESG and Sustainability
Economic Sanctions & Export Controls
Egypt
Employment, Compensation & Benefits
Energy
Energy Transition
Enforcement of Arbitral Awards & Judgments
Environment & Climate Change
European state aid
Financial Institutions
Financial Restructuring and Insolvency
Financial Services Regulatory
Finland
Fintech
Foreign Direct Investment (FDI) Reviews
Foreign Subsidies Regulation (FSR)
France
Germany
Green LNG
Hong Kong SAR
Hydrogen
India
Indonesia
Infrastructure, Transportation & Logistics
Intellectual Property
International Arbitration
International Trade
Investment Funds
Islamic Finance
Israel
Italy
Japan
Kazakhstan
Korea
Latin America
Luxembourg
Mainland China
Maritime & Offshore
Media
Merger control
Mergers & Acquisitions
Mexico
Middle East
Mining & Metals
Nordic
North America
Nuclear Energy
Oman
Pharmaceutical antitrust litigation
Pharmaceuticals & Healthcare
Philippines
Poland
Power
Private Credit & Direct Lending
Private Equity
Private Wealth & Family Offices
Pro Bono
Project Development and Finance
Qatar
Real Estate
Real Estate Finance
Regulatory & Compliance
Renewable Energy
Saudi Arabia
Securities Litigation & Regulatory Enforcement
Shareholder Activism
Singapore
South Africa
Sovereigns
Spain
Sports
Sweden
Switzerland
Taiwan
Tax
Technology
Technology Transactions
Türkiye
UAE
US Public Company Advisory
United Kingdom
United States
Vietnam
Western Europe
White Collar/Investigations
FPI-Specific Memos
Reset
Alert
19 January 2023
Key Considerations for the 2023 Annual Reporting Season: Form 20-F and other FPI-Specific Considerations
Alert
01 February 2022
Key Considerations for the 2022 Annual Reporting Season: Form 20-F and Other FPI-Specific Considerations
Search Dialog
×
×
Close
Share a link to this page
Email
LinkedIn
X
Facebook
